NTRC Competitors and Similar CompaniesClear all
AVEO Pharmaceuticals's competitors and similar companies include Candel Therapeutics.
 AVEO Pharmaceuticals AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. |  Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. | |
Founding Date | Founding Date 2001 | Founding Date 1999 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Boston, US HQ | Locations Needham, US HQ |
Employees | Employees 1912% increase | Employees 50 |
Valuation ($) | Valuation ($) 515.6 m | Valuation ($) 176.8 m |
Financial | ||
Net income | Net income ($53.3m) (FY, 2021) | Net income ($38.2m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 224m | Total funding raised $ 64.6m |
For sources of this data, please see the company profile
View Company Profiles
Candel Therapeutics
HQ
Needham, US
Employees
50
Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies.
View company